Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zeotech Limited ( (AU:ZEO) ) just unveiled an update.
Zeotech reported a strong March quarter, advancing commercialisation of its AusPozz high-reactivity metakaolin through expanded industry collaboration, technical validation and trial activity with major construction stakeholders. The company also progressed development of its Toondoon Kaolin Project, prepared kaolin DSO and cosmetic products for shipment to support marketing and offtake discussions, and secured an Australian patent for its impurity-free synthetic zeolite production technology.
An extended MOU with Holcim Australia and a new MOU with engineering group icubed will underpin further concrete trials and potential deployment of AusPozz in large-scale infrastructure and renewable projects, reinforcing Zeotech’s positioning in low-carbon construction materials. Zeotech also moved its methane control program into on-site landfill trials and strengthened operational capability with a senior project director appointment, signalling readiness to execute near-term development milestones and enhance its market presence.
The most recent analyst rating on (AU:ZEO) stock is a Buy with a A$0.15 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
More about Zeotech Limited
Zeotech Limited is an Australian materials technology company focused on kaolin-based products, low-carbon cement additives and proprietary synthetic zeolite technologies. Its portfolio includes AusPozz high-reactivity metakaolin for greener concrete, kaolin direct shipping ore and cosmetic-grade kaolin, with development centred on the Toondoon Kaolin Project in Queensland.
Average Trading Volume: 977,018
Technical Sentiment Signal: Buy
Current Market Cap: A$152.2M
For a thorough assessment of ZEO stock, go to TipRanks’ Stock Analysis page.

